# Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

> **NCT02736474** · PHASE4 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 22 (actual)

## Conditions studied

- Obese
- Cigarette-smoking
- Schizophrenia

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Placebo Naltrexone
- **DRUG:** Bupropion
- **DRUG:** Placebo Bupropion

## Key facts

- **NCT ID:** NCT02736474
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736474, "Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02736474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*